AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lite Strategy, Inc. Director's Dealing 2021

Nov 23, 2021

34267_dirs_2021-11-23_8da35540-566f-4e5e-8df1-f3a75e0b8bfa.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2021-11-22

Reporting Person: KANGO SUJAY (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct